EP1556427A2 - Materiau macroporeux se presentant sous la forme de perles de matieres plastiques - Google Patents
Materiau macroporeux se presentant sous la forme de perles de matieres plastiquesInfo
- Publication number
- EP1556427A2 EP1556427A2 EP03750435A EP03750435A EP1556427A2 EP 1556427 A2 EP1556427 A2 EP 1556427A2 EP 03750435 A EP03750435 A EP 03750435A EP 03750435 A EP03750435 A EP 03750435A EP 1556427 A2 EP1556427 A2 EP 1556427A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- monomers
- material according
- perien
- macroporous plastic
- macroporous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920003023 plastic Polymers 0.000 title claims abstract description 34
- 239000004033 plastic Substances 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 title claims abstract description 32
- 239000011049 pearl Substances 0.000 title abstract 2
- 239000000178 monomer Substances 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229920001577 copolymer Polymers 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000002245 particle Substances 0.000 claims abstract description 14
- 239000003446 ligand Substances 0.000 claims abstract description 11
- 230000000269 nucleophilic effect Effects 0.000 claims abstract description 7
- 238000004132 cross linking Methods 0.000 claims abstract description 5
- 125000000524 functional group Chemical group 0.000 claims abstract description 5
- 239000011324 bead Substances 0.000 claims description 35
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 21
- 230000007062 hydrolysis Effects 0.000 claims description 16
- 238000006460 hydrolysis reaction Methods 0.000 claims description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 claims description 14
- 108090001060 Lipase Proteins 0.000 claims description 13
- 102000004882 Lipase Human genes 0.000 claims description 13
- 239000004367 Lipase Substances 0.000 claims description 12
- QUMXDOLUJCHOAY-UHFFFAOYSA-N alpha-methylbenzyl acetate Natural products CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 claims description 12
- 235000019421 lipase Nutrition 0.000 claims description 12
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 claims description 12
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 9
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 8
- 230000008961 swelling Effects 0.000 claims description 8
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 6
- 238000010557 suspension polymerization reaction Methods 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical class OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract description 5
- 238000006116 polymerization reaction Methods 0.000 abstract description 4
- 229920002554 vinyl polymer Polymers 0.000 abstract 3
- 238000010526 radical polymerization reaction Methods 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 229920000642 polymer Polymers 0.000 description 16
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 12
- 239000011521 glass Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 6
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000001087 glyceryl triacetate Substances 0.000 description 6
- 235000013773 glyceryl triacetate Nutrition 0.000 description 6
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 229960002622 triacetin Drugs 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000004448 titration Methods 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000000466 oxiranyl group Chemical group 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000008057 potassium phosphate buffer Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 3
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 3
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 3
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 101150073480 CIS1 gene Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 2
- 101100110279 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ATG31 gene Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QUMXDOLUJCHOAY-MRVPVSSYSA-N [(1r)-1-phenylethyl] acetate Chemical class CC(=O)O[C@H](C)C1=CC=CC=C1 QUMXDOLUJCHOAY-MRVPVSSYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- WAPNOHKVXSQRPX-SSDOTTSWSA-N (R)-1-phenylethanol Chemical compound C[C@@H](O)C1=CC=CC=C1 WAPNOHKVXSQRPX-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LGJCFVYMIJLQJO-UHFFFAOYSA-N 1-dodecylperoxydodecane Chemical compound CCCCCCCCCCCCOOCCCCCCCCCCCC LGJCFVYMIJLQJO-UHFFFAOYSA-N 0.000 description 1
- 239000001875 1-phenylethyl acetate Substances 0.000 description 1
- QKPKBBFSFQAMIY-UHFFFAOYSA-N 2-ethenyl-4,4-dimethyl-1,3-oxazol-5-one Chemical compound CC1(C)N=C(C=C)OC1=O QKPKBBFSFQAMIY-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- PAKCOSURAUIXFG-UHFFFAOYSA-N 3-prop-2-enoxypropane-1,2-diol Chemical compound OCC(O)COCC=C PAKCOSURAUIXFG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000187362 Actinomadura Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- -1 B. MPEGMA350 Chemical compound 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000588881 Chromobacterium Species 0.000 description 1
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N alpha-methylbenzylalcohol Natural products CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- QCCDLTOVEPVEJK-UHFFFAOYSA-N phenylacetone Chemical compound CC(=O)CC1=CC=CC=C1 QCCDLTOVEPVEJK-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/12—Polymerisation in non-solvents
- C08F2/16—Aqueous medium
- C08F2/18—Suspension polymerisation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/285—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety
- C08F220/286—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety and containing polyethylene oxide in the alcohol moiety, e.g. methoxy polyethylene glycol (meth)acrylate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
Definitions
- the invention relates to the field of polymer carrier systems and, in particular, to a macroporous plastic bead material containing a copolymer of crosslinked (meth) acrylate plastic.
- Polymer carrier systems containing copolymers of crosslinked (meth) acrylate plastic are known, for. B. from EP-A 0 328767, EP-A 424 130, EP-A 579 928 or from WO 99/33964.
- WO 99/40122 (DE-A 19804518) relates to a process for the preparation of a bead-shaped, crosslinked hydrophilic copolymer which is active against ligands with nucleophilic groups by inverse suspension polymerization of a monomer phase.
- the invention further relates to the carrier polymer materials obtainable therefrom with a high binding capacity for penicillin amidase and a low swelling number and the use thereof.
- copolymer of crosslinked (meth) acrylate plastic is obtained by inverse suspension polymerization of the following monomers:
- the copolymer is suitable as a carrier material for various types of enzymes.
- macroporous plastic bead materials should be provided which are suitable as efficient carrier materials, in particular for enzymes which are able to convert relatively hydrophobic substrates, preferably for lipases.
- macroporous plastic bead materials should be provided which, after binding lipases, show comparatively high activities in test systems such as tributyrin hydrolysis, triacetin hydrolysis, phenylethyl acetate hydrolysis and / or phenylethyl acetate synthesis.
- the object is achieved by a macroporous plastic bead material with an average particle diameter in the range from 10 to 1000 ⁇ m, containing a copolymer
- the macroporous plastic bead material has an average particle diameter V 50 of 10 to 1000, preferably from 50 to 600, particularly preferably from 100 to 500, in particular from 200 to 400 ⁇ m.
- the determination of the average particle diameter V 50 can, for. B. with a particle analyzer.
- a sample with a particle concentration in the range of 10 3 -10 6 particles is mixed with some detergent as a wetting aid and additionally treated with ultrasound before the measurement to separate the particles.
- the macroporous plastic bead material can have a porosity which can be measured by a Kp S ⁇ o value of 0.3 to 0.9, in particular from 0.35 to 0.6.
- B. characterizes by inverse size exclusion chromatography in tetrahydrofuran.
- the macroporous plastic bead material can have a swelling number in water from 1 to 1.5, in particular from 1.05 to 1.2.
- the copolymer consists of the free-radically polymerized units of the monomer types a) to d) which are present in the proportions given and generally add up to 100% by weight.
- the properties for the implementation of hydrophobic substrates are essentially determined by the selection of the monomers in detail and their quantitative proportions. In particular, the balance of the more hydrophilic monomer types a) and the more hydrophobic monomer types d) seem to have an important influence on the implementation of hydrophobic substrates.
- the binding properties for enzymes are influenced in particular by the selection and the proportion of the monomer type b).
- the monomer type c) influences the size and porosity of the plastic beads. Size and porosity in turn influence the binding capacity for enzymes and their catalysis behavior in the bound state.
- the copolymers can also contain small amounts of further vinyl-polymerizable monomers without their essential properties having to be significantly impaired in individual cases.
- the copolymers consist of 100% radical-polymerized units, the monomers a) to d).
- Monomers a) contain 5-60, preferably 10 to 50% by weight of vinylically polymerizable monomers with a water solubility of at least 1% at 20 ° C. in the copolymer.
- Particularly suitable monomers a) are acrylamide and / or methacrylamide, hydroxyalkyl esters of unsaturated polymerizable carboxylic acids, such as hydroxyethyl acrylate, hydroxyethyl methacrylate, hydroxypropyl acrylate, hydroxypropyl methacrylate.
- z. B N-vinyl pyrrolidone, methyl methacrylate or 3-allyloxy-1, 2-propanediol.
- Methyl methacrylate and methoxypolyethylene glycol methacrylate are preferred.
- MPEGMA methoxypolyethylene glycol methacrylate
- PEGMA polyethylene glycol methacrylate
- MPEGMA350 methoxypolyethylene glycol methacrylate 350
- PEGMA polyethylene glycol methacrylate
- Monomers b) contain 1-40, preferably 10 to 30% by weight of vinylically polymerizable monomers which have an additional functional group, preferably an oxirane group (epoxy group) which can form covalent bonds in a reaction with nucleophilic groups of ligands, are provided.
- an additional functional group preferably an oxirane group (epoxy group) which can form covalent bonds in a reaction with nucleophilic groups of ligands
- ligands are preferably biologically active molecules, especially macromolecules, e.g. B. amino acids, peptides, proteins, especially enzymes such as. B. lipases, but also nucleic acids or polysaccharides. Oxirane groups in particular are suitable for binding ligands while maintaining their biological activity.
- Suitable monomers b) are glycidyl methacrylate and / or allyl glycidyl ether and / or vinyl azlactone.
- Glycidyl methacrylate is preferred, particularly preferably in an amount of 15 to 25% by weight.
- Monomers c) contain 10-40, preferably 20 to 35% by weight of hydrophilic, crosslinking, radically polymerizable monomers with two or more ethylenically unsaturated polymerizable groups.
- B. hydrophilic di (meth) acrylates such as. B. ethylene glycol di (meth) acrylate and polyethylene oxide di (meth) acrylates.
- Suitable monomers c) are also N, N ' -methylene-bis-acrylamide or N, N ' -methylene-bis-methacrylamide.
- Preferred monomer c) is 1,4-butanediol dimethacrylate.
- Monomers d) contain 10-60, preferably 10-30% by weight of vinylically polymerizable monomers with a water solubility of at most 1% at 20 ° C.
- Suitable monomers d) are, for. B. isobutyl methacrylate, n-butyl methacrylate, cyclohexyl methacrylate, benzyl methacrylate and 2-ethylhexyl methacrylate. production method
- the macroporous plastic bead material consisting of the copolymers can be prepared in a manner known per se by means of suspension polymerization (bead polymerization).
- An aqueous phase, which in particular distributors, for. B. contains precipitated aluminum hydroxide, placed in a stirred reactor.
- the monomers are then used together with a polymerization initiator, e.g. B. dilauryl peroxide, in an organic phase, e.g. B. cyclohexane added.
- the phases are dispersed with stirring, the polymerization of the monomers z. B. can be done in a temperature range of 60 to 80 ° C.
- the macroporous plastic bead material can be obtained from the batch by filtration and drying.
- Variants of the copolymers on which the enzyme lipase from Candida antarctica was immobilized are said to have good results in the following test systems.
- the enzyme immobilization can e.g. B. by incubating the macroporous plastic bead material with a commercially available enzyme solution (z. B. Novozym® 525F) in aqueous solution for 1 to 2 days at room temperature. The plastic bead material coupled with the enzyme is then washed and dried. The immobilizates obtained in this way can be tested in the following test systems.
- tributyrin hydrolysis activity of have at least 150 [U / g], preferably at least 300 [U / g], in particular at least 500 [U / g].
- the immobilizate of macroporous plastic bead material and lipase from Candida antarctica can e.g. B. have a triacetin hydrolysis activity of at least 50 [U / g], preferably at least 100 [U / g], in particular at least 150 [U / g].
- the immobilizate of macroporous plastic bead material and lipase from Candida antarctica can e.g. B. have a phenylethyl acetate hydrolysis activity of at least 80 [U / g], preferably at least 100 [U / g], in particular at least 150 [U / g].
- Racemate resolution of 1-phenylethanol by transesterification (non-aqueous system).
- the immobilizate of copolymer and lipase from Candida antarctica can, for. B. have a phenylethanol racemate cleavage activity of at least 100 [U / g], preferably at least 120 [U / g], in particular at least 180 [U / g].
- the macroporous plastic bead material can be used for the immobilization of peptides, proteins, nucleic acids or polysaccharides, preferably for the immobilization of lipases from Rhizopus, Aspergillus, Mucor, Alcaligenes, Candida, Pseudomonas, Thermomyces, Chromobacterium, porcine pancreas, and for the immobilization of phospholipases Streptomyces and Actinomadura, as well as for the immobilization of esterases from pig liver and orange peel.
- the macroporous plastic bead materials according to the invention can be used as carrier materials for the covalent binding of ligands by means of the oxirane groups present in stirred or flow reactors.
- This can e.g. B. by addition of proteins, in particular enzymes, from concentrated solutions via covalent binding while maintaining their biological activity.
- proteins, in particular enzymes from concentrated solutions via covalent binding while maintaining their biological activity.
- peptides, amino acids, lipids, nucleotides, polynucleotides, low molecular weight nucleophilic compounds or organometallic compounds can also be reacted with the oxirane groups of the carrier beads.
- the polymer beads loaded with ligands can be used in a manner known per se for the stereospecific synthesis of chiral substances, such as amino acids (d-phenylalamine, p-hydroxy-d-phenylalanine, l-tert.-leucine) or drugs, e.g. B. ß-lactam antibiotics, ibuprofen can be used.
- amino acids d-phenylalamine, p-hydroxy-d-phenylalanine, l-tert.-leucine
- drugs e.g. B. ß-lactam antibiotics, ibuprofen can be used.
- the polymer beads can also be used in the separation technique for adsorption chromatography or gel permeation chromatography. For specific adsorption, the polymer beads can be loaded with immunoglobulin fractions from antisera or with monoclonal antibodies.
- Another area of application is the use of the carrier polymer material loaded with enzymes or antibodies as an adsorbent in extracorporeal therapy, in which pathogenic or toxic substances are removed from whole blood.
- MPEGMA350 methoxypolyethylene glycol methacrylate 350
- Example 1 Manufacturing instructions for mixed polymer variant 13
- the total amount of water [810g] and the aluminum sulfate [5.4g] are placed in a 2L stirred reactor comprising a thermocouple, bath thermostat, reflux condenser, nitrogen inlet tube with stirring and nitrogen inlet and heated to 70 ° C.
- the soda solution [24g] is added in one go to precipitate the aluminum hydroxide.
- the auxiliary distributors C15 paraffin sulfonate, Na salt and polyethylene glycol 5000/6000 [0.05 g each] are then added.
- the pH of the water phase is approximately 5.5. After that:
- the total amount of water [810g] and the aluminum sulfate [5.4g] are placed in a 2L stirred reactor, comprising a thermocouple, bath thermostat, reflux condenser, nitrogen inlet tube with stirring and nitrogen inlet and heated to 70 ° C.
- a 2L stirred reactor comprising a thermocouple, bath thermostat, reflux condenser, nitrogen inlet tube with stirring and nitrogen inlet and heated to 70 ° C.
- the soda solution [24g] is added in one go to precipitate the aluminum hydroxide.
- the auxiliary distributors C15 paraffin sulfonate, Na salt and polyethylene glycol 5000/6000 [0.05 g each] are then added.
- the pH of the water phase is approximately 5.5. After that:
- the average particle diameter is measured with a CIS1 particle analyzer from LOT GmbH.
- Sample preparation Place enough sample in a 400 ml beaker to reach a concentration of 10 3 -10 6 particles. Then a few drops of detergent are added to the sample as a wetting aid. Then it is filled up with 350 ml deionized water. The suspension obtained is treated with ultrasound for about 1 minute and then measured in the CIS1 device, measuring range 5-600 ⁇ m.
- the proportion of the pore volume which is accessible to the probe molecule used is determined by inverse size exclusion chromatography (SEC).
- SEC inverse size exclusion chromatography
- the distribution coefficient obtained in this way is a measure of the porosity of the sample.
- a Merck Superformance glass column 300x10 mm is filled with the bead polymer using THF and tetrachlorethylene according to the balanced density principle. The column is then packed and equilibrated by delivering 150 ml of THF at a flow rate of 15 ml / min. The column is then closed and a further 150 ml of tetrahydrofuran (THF) are pumped at a flow rate of 10 ml / min.
- THF tetrahydrofuran
- probe molecules are placed one after the other on the column and eluted at a flow rate of 0.2 ml / min.
- the exclusion limits are determined with o-dichlorobenzene and polystyrene 6770000 (molecular weight 6770000 daltons), polystyrene 10200 (molecular weight 10200 daltons) is used as the probe molecule.
- the distribution coefficient is calculated from the elution volumes as follows:
- KpsiO VE (PS10200) - VE (PS6770000) / VE (o-dichlorobenzene) - VE (PS6770000)
- KPSIO distribution coefficient for polystyrene 10200
- VE (PS ⁇ 77 OO OO ) elution volume of the exclusion marker polystyrene 6770000
- VE (o-dichlorobenzene) elution volume of the exclusion marker o-dichlorobenzene.
- pH stat titrator e.g. B. Mettler DL 50
- pH stat titrator e.g. B. Schott Titroline Alpha 100 ml double-walled glass vessel Thermostatic water bath stirring station Radiometer TTA 80 pH electrode Schott Blue Line 10 ml burette
- the reaction vessel is thermostatted to 25 ° C. 16 ml of 0.05M potassium phosphate buffer pH 7.0 are introduced, 100 mg of the investigating immobilisates are added. Then the stirring is started. The reaction is started by adding 400 ⁇ l triacetin. The connected titrator registers the alkali consumption depending on the hydrolysis time. The activity of the enzyme is determined from the linear slope of the curve. The activity in U / g immobilizate can be calculated directly from the value obtained therefrom in ml NaOH / min per amount of enzyme used.
- pH stat titrator e.g. B. Mettler DL 50
- Table A Examples of polymer supports produced according to the invention, immobilization method M3-aMEK.
- Table B Examples of polymer supports produced according to the invention, immobilization method M2.
- Polymer A Commercially available, macroporous, crosslinked plastic bead material
- Polymer B Commercially available, macroporous, crosslinked plastic bead material
- polymer C corresponds to polymer A, but has a lower swelling number ( ⁇ 1.5) (preparation according to DE-A 19804518).
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymerisation Methods In General (AREA)
Abstract
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251144 | 2002-10-31 | ||
| DE10251144A DE10251144A1 (de) | 2002-10-31 | 2002-10-31 | Makroporöses Kunststoffperlenmaterial |
| PCT/EP2003/009378 WO2004039854A2 (fr) | 2002-10-31 | 2003-08-25 | Materiau macroporeux se presentant sous la forme de perles de matieres plastiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1556427A2 true EP1556427A2 (fr) | 2005-07-27 |
Family
ID=32115155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03750435A Withdrawn EP1556427A2 (fr) | 2002-10-31 | 2003-08-25 | Materiau macroporeux se presentant sous la forme de perles de matieres plastiques |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7381552B2 (fr) |
| EP (1) | EP1556427A2 (fr) |
| JP (1) | JP2006504816A (fr) |
| KR (1) | KR20050084753A (fr) |
| CN (1) | CN1283680C (fr) |
| AU (1) | AU2003270100A1 (fr) |
| DE (1) | DE10251144A1 (fr) |
| IL (2) | IL162081A0 (fr) |
| WO (1) | WO2004039854A2 (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10043868A1 (de) * | 2000-09-04 | 2002-04-04 | Roehm Gmbh | PMMA Formmassen mit verbesserter Schlagzähigkeit |
| CA2437045C (fr) * | 2001-02-07 | 2010-09-14 | Guenter Schmitt | Matiere de scellement a chaud pour feuilles d'aluminium appliquees contre du polypropylene et du polystyrene |
| DE10127134A1 (de) * | 2001-06-05 | 2002-12-12 | Roehm Gmbh | verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß |
| DE10236240A1 (de) * | 2002-02-06 | 2003-08-14 | Roehm Gmbh | Silicon-Pfropfcopolymerisate mit Kern-Hülle-Struktur, schlagzähmodifizierte Formmassen und Formkörper sowie Verfahren zu deren Herstellung |
| DE10243062A1 (de) * | 2002-09-16 | 2004-03-25 | Röhm GmbH & Co. KG | Heißwasserwechseltestbeständiges Sanitärmaterial aus PMMA-Formmasse oder schlagzäher PMMA-Formmasse |
| DE10260065A1 (de) | 2002-12-19 | 2004-07-01 | Röhm GmbH & Co. KG | Kern-Schale-Teilchen zur Schlagzähmodifizierung von Poly(meth)acrylat-Formmassen |
| DE10260089A1 (de) * | 2002-12-19 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von wässrigen Dispersionen |
| DE10320318A1 (de) * | 2003-05-06 | 2004-12-02 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von lichtstreuenden Formteilen mit hervorragenden optischen Eigenschaften |
| DE10345045A1 (de) * | 2003-09-26 | 2005-04-14 | Röhm GmbH & Co. KG | Verfahren zur Oberflächenvergütung von Werkstoffen durch Aufbringen insbesondere transparenter Schichten auf Basis von Polymethacrylaten |
| DE10349144A1 (de) * | 2003-10-17 | 2005-05-12 | Roehm Gmbh | Polymermischung für mattierte Spritzgußteile |
| MX2007008855A (es) * | 2003-10-18 | 2008-03-13 | Roehm Gmbh | Masas de pieza moldeada de poli (met) acrilato resistentes a impactos con alta estabilidad termica. |
| DE10351535A1 (de) | 2003-11-03 | 2005-06-09 | Röhm GmbH & Co. KG | Mehrschichtfolie aus (Meth)acrylatcopolymer und Polycarbonat |
| DE10354379A1 (de) | 2003-11-20 | 2005-06-23 | Röhm GmbH & Co. KG | Formmasse, enthaltend ein Mattierungsmittel |
| DE102004022540A1 (de) * | 2004-05-05 | 2005-12-08 | Röhm GmbH & Co. KG | Formmasse für Formkörper mit hoher Witterungsbeständigkeit |
| DE102004045296A1 (de) * | 2004-09-16 | 2006-03-23 | Röhm GmbH & Co. KG | Verwendung von Polyalkyl (meth) acrylat-Perlpolymerisaten und Formmasse zur Herstellung von extrudierten Formteilen mit mattierter Oberfläche |
| DE102004058083A1 (de) | 2004-12-01 | 2006-06-08 | Röhm GmbH & Co. KG | Gedeckt eingefärbte, infrarotreflektierende Kunststoffformmasse |
| DE102005002072A1 (de) * | 2005-01-14 | 2006-07-20 | Röhm GmbH & Co. KG | Witterungsstabile Folie zur Gelbeinfärbung retroreflektierender Formkörper |
| DE102005005828A1 (de) * | 2005-02-08 | 2006-08-17 | Röhm GmbH & Co. KG | Makroporöses Kunststoffperlenmaterial |
| JP2006258458A (ja) * | 2005-03-15 | 2006-09-28 | Sumitomo Bakelite Co Ltd | 医療材料用高分子化合物及び該高分子化合物を用いたバイオチップ用基板 |
| MX2007012957A (es) * | 2005-04-18 | 2008-03-13 | Evonik Roehm Gmbh | Material de moldeo y pieza moldeada que comprende un termoplastico que contiene particulas inorganicas de nanoescala, proceso para la preparacion del material de moldeo y uso de los mismos. |
| DE102005021335A1 (de) * | 2005-05-04 | 2006-11-09 | Röhm Gmbh | Verfahren zur Herstellung von Perlpolymerisaten mit einer mittleren Teilchengröße im Bereich von 1 µm bis 40 µm sowie Perlpolymerisat aufweisende Formmassen und Formkörper |
| DE102005055793A1 (de) | 2005-11-21 | 2007-05-24 | Röhm Gmbh | Transparente TPU (thermoplastische Polyurethane)/ PMMA (Polymethyl(meth)acrylat) Abmischungen mit verbesserter Kältesschlagzähigkeit |
| DE102006029613A1 (de) * | 2006-06-26 | 2007-12-27 | Röhm Gmbh | Transparenter Kunststoff-Verbund |
| US20080035703A1 (en) * | 2006-08-09 | 2008-02-14 | Daewoong Suh | Oxidation resistant solder preform |
| JP5364971B2 (ja) * | 2006-09-28 | 2013-12-11 | 住友ベークライト株式会社 | 生理活性物質の固定化方法 |
| JP5364973B2 (ja) * | 2006-11-22 | 2013-12-11 | 住友ベークライト株式会社 | 生理活性物質の固定化方法 |
| DE102007005432A1 (de) * | 2007-01-30 | 2008-07-31 | Evonik Röhm Gmbh | Formmassen für mattierte Polyacrylat-Formkörper |
| DE102007026200A1 (de) * | 2007-06-04 | 2008-12-11 | Evonik Röhm Gmbh | Zusammensetzung mit erhöhter Spannungsrissbeständigkeit |
| DE102007026201A1 (de) * | 2007-06-04 | 2008-12-11 | Evonik Röhm Gmbh | Eingefärbte Zusammensetzung mit erhöhter Spannungsrissbeständigkeit |
| DE102007028601A1 (de) | 2007-06-19 | 2008-12-24 | Evonik Röhm Gmbh | Reaktivgemisch zur Beschichtung von Formkörpern mittels Reaktionsspritzguss sowie beschichteter Formkörper |
| DE102007029263A1 (de) * | 2007-06-22 | 2008-12-24 | Evonik Röhm Gmbh | PMMA/PVDF-Folie mit besonders hoher Witterungsbeständigkeit und hoher UV-Schutzwirkung |
| DE102007051482A1 (de) * | 2007-10-25 | 2009-04-30 | Evonik Röhm Gmbh | Verfahren zur Herstellung von beschichteten Formkörpern |
| JP5365623B2 (ja) * | 2008-03-11 | 2013-12-11 | 住友ベークライト株式会社 | 生理活性物質の固定化方法 |
| DE102008001231A1 (de) * | 2008-04-17 | 2009-10-22 | Evonik Röhm Gmbh | Flammfeste PMMA-Formmasse |
| DE102008001695A1 (de) * | 2008-05-09 | 2009-11-12 | Evonik Röhm Gmbh | Poly(meth)acrylimide mit verbesserten optischen und Farbeigenschaften, insbesondere bei thermischer Belastung |
| US8574835B2 (en) | 2009-05-29 | 2013-11-05 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
| US20110306148A1 (en) | 2010-06-14 | 2011-12-15 | Siemens Healthcare Diagnostics Inc. | Composition for use as an assay reagent |
| US8889373B2 (en) | 2010-08-12 | 2014-11-18 | Eastman Chemical Company | Enzyme catalyst immobilized on porous fluoropolymer support |
| ES2386918B1 (es) * | 2011-02-09 | 2013-10-30 | Consejo Superior De Investigaciones Científicas | Un procedimiento de obtención de 1,2-diacetina |
| WO2013062841A1 (fr) * | 2011-10-26 | 2013-05-02 | Bio-Rad Laboratories, Inc. | Élimination des agents virucides en chromatographie en mode mixte |
| CN114106252B (zh) * | 2021-12-13 | 2022-11-08 | 科睿驰(深圳)医疗科技发展有限公司 | 显色栓塞微球及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3106456A1 (de) * | 1981-02-21 | 1982-10-07 | Röhm GmbH, 6100 Darmstadt | Verfahren zur herstellung von perlfoermigen, hydrophilen, gegenueber proteinen bindungsaktiven traegerpolymeren |
| US5658769A (en) * | 1993-07-02 | 1997-08-19 | Unichem Chemie Bv | Process for the esterification of carboxylic acids with tertiary alcohols using a lipase from Candida antarctica |
| US6048908A (en) * | 1997-06-27 | 2000-04-11 | Biopore Corporation | Hydrophilic polymeric material |
| DE19804518C2 (de) * | 1998-02-05 | 2000-10-05 | Roehm Gmbh | Verfahren zur Herstellung von perlförmigen Mischpolymerisaten auf Acrylatbasis, danach hergestellte Trägerpolymermaterialien und deren Verwendung |
| DE10256656A1 (de) | 2002-12-03 | 2004-06-17 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Cephalexin |
-
2002
- 2002-10-31 DE DE10251144A patent/DE10251144A1/de not_active Withdrawn
-
2003
- 2003-08-25 KR KR1020047010414A patent/KR20050084753A/ko not_active Ceased
- 2003-08-25 IL IL16208103A patent/IL162081A0/xx unknown
- 2003-08-25 AU AU2003270100A patent/AU2003270100A1/en not_active Abandoned
- 2003-08-25 JP JP2004547483A patent/JP2006504816A/ja active Pending
- 2003-08-25 US US10/498,971 patent/US7381552B2/en not_active Expired - Fee Related
- 2003-08-25 EP EP03750435A patent/EP1556427A2/fr not_active Withdrawn
- 2003-08-25 WO PCT/EP2003/009378 patent/WO2004039854A2/fr not_active Ceased
- 2003-08-25 CN CNB038018942A patent/CN1283680C/zh not_active Expired - Fee Related
-
2004
- 2004-05-20 IL IL162081A patent/IL162081A/en not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004039854A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1076634A1 (en) | 2006-01-20 |
| WO2004039854A2 (fr) | 2004-05-13 |
| WO2004039854A3 (fr) | 2004-07-15 |
| CN1612903A (zh) | 2005-05-04 |
| JP2006504816A (ja) | 2006-02-09 |
| US7381552B2 (en) | 2008-06-03 |
| US20050065224A1 (en) | 2005-03-24 |
| IL162081A (en) | 2008-07-08 |
| KR20050084753A (ko) | 2005-08-29 |
| IL162081A0 (en) | 2005-11-20 |
| DE10251144A1 (de) | 2004-05-19 |
| CN1283680C (zh) | 2006-11-08 |
| AU2003270100A1 (en) | 2004-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1556427A2 (fr) | Materiau macroporeux se presentant sous la forme de perles de matieres plastiques | |
| DE3886412T2 (de) | Verfahren zur immobilisierung von lipasen. | |
| DE2402809C2 (de) | Verfahren zur Herstellung eines mit Bromcyan aktivierten, trockenen hydrophilen polymeren Trägers für biologisch wirksame Verbindungen | |
| EP0071704B1 (fr) | Systèmes riches en surfaces pour fixer des substrats contenant des groupes nucléophiles | |
| EP0110281B1 (fr) | Polymères de carbonate de vinylène, leur procédé de préparation et leur usage | |
| EP0129719A2 (fr) | Polymères macroporeux en perles, procédé de leur préparation et leur usage | |
| DE2552510A1 (de) | Biologisch aktive verbindungen und verfahren zu ihrer herstellung | |
| US4582860A (en) | Oxirane resins for enzyme immobilization | |
| DE3344912C2 (fr) | ||
| DE69412651T2 (de) | Vernetzte Isocyanatgruppen enthaltende Polymer-Träger | |
| DE19804518C2 (de) | Verfahren zur Herstellung von perlförmigen Mischpolymerisaten auf Acrylatbasis, danach hergestellte Trägerpolymermaterialien und deren Verwendung | |
| EP0266503B1 (fr) | Polymères réticulés et leur procédé de préparation | |
| DE69002459T2 (de) | Immobilisierte lipaseherstellung und deren verwendung zur herstellung von estern. | |
| EP0257632B1 (fr) | Polymères réticulés avec des groupes carbonate-ester et leur procédé de préparation | |
| EP0482339A1 (fr) | Support hydrophile, activable, sous forme de perles et hautement réticulé | |
| US4612288A (en) | Oxirane resins for enzyme immobilization | |
| CH680668A5 (fr) | ||
| EP0492495A2 (fr) | D-amino acide oxydase immobilisé et son utilisation pour la préparation de médicaments | |
| WO2006084490A1 (fr) | Matiere pour perles de matiere plastique macroporeuse | |
| DE2340520C2 (de) | Verfahren zur Herstellung von hydrophilen merkurierten Polymeren | |
| DE2805366C2 (fr) | ||
| DE1695662C3 (de) | Trägergebundene proteinartige Wirkstoffe | |
| DE2537339A1 (de) | Menthyllactatesterase, ihre gewinnung und verwendung | |
| DE3910966A1 (de) | Mit enzymen beschichtetes traegermaterial | |
| DE3416142A1 (de) | Verfahren zur herstellung von immobilisiertem biologischem material in perlform |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040515 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ROEHM GMBH |
|
| 17Q | First examination report despatched |
Effective date: 20061124 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EVONIK ROEHM GMBH |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EVONIK ROEHM GMBH |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090402 |